$KEQU

Ranade Mandar sold (to issuer) $65K of KEQU

Ranade Mandar (SVP, IT & Engineering) sold (to issuer) 1,800 shares of KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) at $36.25 on 2026-06-30.

Original reporting
SEC EDGAR · Ranade Mandar
Published Jul 2, 2026, 3:55 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 2, 2026, 3:56 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$KEQU
Neutral
high confidence
Mentioned
$KEQU
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KEQUNeutralLow
01

Why it matters

The newest fact is the reported sale of 1,800 shares at $36.25 on 2026-06-30; absent other company news, it mainly updates insider activity records.

02

Market read

Traders may note insider selling activity, but the filing provides no new operational/financial catalyst.

03

What to watch

Check whether there are multiple insider transactions around the same period, and whether the issuer’s buyback/repurchase program mechanics explain “sale to issuer” activity.

Relevance 3/10Novelty 5/10Timing: filed 2026-07-02 (after-hours/late day) for 2026-06-30 sale

Background

The article is an SEC Form 4 insider transaction disclosure for KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU).

Company-level read

Ticker impact

$KEQUNeutralHigh confidence
Context

Ranade Mandar (SVP, IT & Engineering) sold 1,800 KEQU shares to the issuer at $36.25 on 2026-06-30, per Form 4.

Expected impact

Low near-term impact; any effect is likely noise unless repeated at unusual frequency or tied to new disclosures.

Evidence & confidence

This is a Form 4 insider transaction with no 10b5-1 plan and no accompanying fundamental catalyst in the filing text; such sales are typically not directionally informative by themselves.

Market effects

No sector-level read-across; this is company-specific insider liquidity disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is to the issuer (often buyback/participation mechanics) and the filing lacks a 10b5-1 plan, the transaction may reflect administrative/plan mechanics rather than bearish conviction.

Key entities

  • KEWAUNEE SCIENTIFIC CORP /DE/

    Subject of the Form 4 insider transaction; ticker KEQU.

  • Ranade Mandar

    SVP, IT & Engineering; reported sale to issuer of 1,800 shares.

Related articles

$KEQUMed

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU): Results of Operations and Financial Condition

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 prfy26q4earningsrelease.htm EX-99.1 Document Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704/871-3274 STATESVILLE, N.C. June 23, 2026 – PRNewswire / Kewaunee Scientific Corporation (NASDAQ